$CTSH
COGNIZANT TECHNOLOGY SOLUTIONS CORP Stock $ctsh

$ctsh Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000105829024000116 Filed on May 02, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$4.850B	$4.760B
YoY Change	-0.74%	-1.08%
Cost Of Revenue	$3.204B	$3.146B
YoY Change	-0.84%	0.1%
Gross Profit	$1.646B	$1.614B
YoY Change	-0.54%	-3.3%
Gross Profit Margin	33.94%	33.91%
Selling, General & Admin	$781.0M	$765.0M
YoY Change	-5.9%	-8.38%
% of Gross Profit	47.45%	47.4%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$128.0M	$131.0M
YoY Change	-9.22%	-0.76%
% of Gross Profit	7.78%	8.12%
Operating Expenses	$781.0M	$896.0M
YoY Change	-18.73%	7.31%
Operating Profit	$708.0M	$718.0M
YoY Change	2.02%	2.28%
Interest Expense	$10.00M	$25.00M
YoY Change	-9.09%	177.78%
% of Operating Profit	1.41%	3.48%
Other Income/Expense, Net	$20.00M	$2.000M
YoY Change	-2100.0%	-94.44%
Pretax Income	$728.0M	$722.0M
YoY Change	24.02%	-2.17%
Income Tax	$165.0M	$179.0M
% Of Pretax Income	22.66%	24.79%
Net Earnings	$566.0M	$546.0M
YoY Change	22.25%	-5.86%
Net Earnings / Revenue	11.67%	11.47%
Basic Earnings Per Share	$1.14	$1.10
Diluted Earnings Per Share	$1.14	$1.10
COMMON SHARES
Basic Shares Outstanding	497.2M shares	497.8M shares
Diluted Shares Outstanding	498.0M shares	498.0M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.205B	$2.243B
YoY Change	5.25%	-9.59%
Cash & Equivalents	$2.193B	$2.231B
Short-Term Investments	$12.00M	$12.00M
Other Short-Term Assets	$1.067B	$1.021B
YoY Change	-3.09%	-0.78%
Inventory
Prepaid Expenses
Receivables	$3.973B	$3.822B
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$7.245B	$7.086B
YoY Change	4.23%	-1.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.009B	$1.625B
YoY Change	-46.19%	47.46%
Goodwill	$6.395B	$6.393B
YoY Change	5.44%	5.84%
Intangibles	$1.129B	$1.171B
YoY Change	-8.06%	-7.21%
Long-Term Investments	$80.00M	$83.00M
YoY Change	-81.18%	33.87%
Other Assets	$1.068B	$2.050B
YoY Change	-24.95%	251.63%
Total Long-Term Assets	$11.34B	$11.32B
YoY Change	2.9%	3.69%
TOTAL ASSETS
Total Short-Term Assets	$7.245B	$7.086B
Total Long-Term Assets	$11.34B	$11.32B
Total Assets	$18.58B	$18.41B
YoY Change	3.41%	1.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$298.0M	$291.0M
YoY Change	-6.29%	-12.35%
Accrued Expenses	$2.224B	$2.239B
YoY Change	18.49%	25.5%
Deferred Revenue
YoY Change
Short-Term Debt	$33.00M	$33.00M
YoY Change		106.25%
Long-Term Debt Due	$33.00M	$33.00M
YoY Change	37.5%	106.25%
Total Short-Term Liabilities	$2.946B	$3.012B
YoY Change	-3.6%	-9.3%
LONG-TERM LIABILITIES
Long-Term Debt	$590.0M	$598.0M
YoY Change	-5.14%	-5.08%
Other Long-Term Liabilities	$448.0M	$1.107B
YoY Change	-61.58%	249.21%
Total Long-Term Liabilities	$1.038B	$1.705B
YoY Change	-41.95%	80.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.946B	$3.012B
Total Long-Term Liabilities	$1.038B	$1.705B
Total Liabilities	$4.682B	$4.918B
YoY Change	-7.54%	-10.35%
SHAREHOLDERS EQUITY
Retained Earnings	$14.03B	$13.62B
YoY Change	7.73%	5.95%
Common Stock	$5.000M	$5.000M
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.90B	$13.49B
YoY Change
Total Liabilities & Shareholders Equity	$18.58B	$18.41B
YoY Change	3.41%	1.44%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$566.0M	$546.0M
YoY Change	22.25%	-5.86%
Depreciation, Depletion And Amortization	$128.0M	$131.0M
YoY Change	-9.22%	-0.76%
Cash From Operating Activities	$262.0M	$95.00M
YoY Change	627.78%	-86.97%
INVESTING ACTIVITIES
Capital Expenditures	$79.00M	$79.00M
YoY Change	16.18%	-19.39%
Acquisitions		$421.0M
YoY Change		2.93%
Other Investing Activities	$0.00	-$159.0M
YoY Change	-100.0%	35.9%
Cash From Investing Activities	-$79.00M	-$238.0M
YoY Change	-7.06%	10.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-221.0M	-304.0M
YoY Change	-37.57%	-13.14%
NET CHANGE
Cash From Operating Activities	262.0M	95.00M
Cash From Investing Activities	-79.00M	-238.0M
Cash From Financing Activities	-221.0M	-304.0M
Net Change In Cash	-38.00M	-447.0M
YoY Change	-90.57%	-372.56%
FREE CASH FLOW
Cash From Operating Activities	$262.0M	$95.00M
Capital Expenditures	$79.00M	$79.00M
Free Cash Flow	$183.0M	$16.00M
YoY Change	-671.88%	-97.46%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	497000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	497000000	shares
CY2023Q1	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#ForeignCurrencyTransactionGainLossBeforeTax
CY2024Q1	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#ForeignCurrencyTransactionGainLossBeforeTax
CY2023Q1	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#ForeignCurrencyTransactionGainLossBeforeTax
CY2024Q1	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#ForeignCurrencyTransactionGainLossBeforeTax
CY2024Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	3146000000	usd
CY2023Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	3143000000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	765000000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	835000000	usd
CY2024Q1	us-gaap	Restructuring Charges RestructuringCharges	23000000	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	131000000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	132000000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	695000000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	702000000	usd
CY2024Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	30000000	usd
CY2023Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	30000000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	11000000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	9000000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	6000000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	12000000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2000000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3000000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	27000000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	36000000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	722000000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	738000000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	179000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	158000000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3000000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	546000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	580000000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.10
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.14
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.10
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.14
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	497000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	509000000	shares
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1000000	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	498000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	509000000	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	546000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	580000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-73000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	43000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	11000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	34000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-62000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	77000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	484000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	657000000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13227000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-62000000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	20000000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	42000000	usd
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	133000000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.30
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	150000000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	13490000000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	12309000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	580000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	77000000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	23000000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	44000000	usd
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	223000000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.29
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	149000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	546000000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	133000000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	132000000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-26000000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-16000000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	42000000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	44000000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-32000000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-27000000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-39000000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-89000000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	347000000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	17000000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-47000000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-26000000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	50000000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	71000000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-327000000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-155000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	95000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	729000000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	79000000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	98000000	usd
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	0	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	225000000	usd
CY2024Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	usd
CY2023Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	3000000	usd
CY2024Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	3000000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	15000000	usd
CY2024Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	0	usd
CY2023Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	26000000	usd
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	259000000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	81000000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	421000000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	409000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-238000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-215000000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	20000000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	23000000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	133000000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	222000000	usd
CY2024Q1	ctsh	Repayments Of Debt Lease And Earnout Obligations RepaymentsOfDebtLeaseAndEarnoutObligations	40000000	usd
CY2023Q1	ctsh	Repayments Of Debt Lease And Earnout Obligations RepaymentsOfDebtLeaseAndEarnoutObligations	1000000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	151000000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	150000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-304000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-350000000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-39000000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-486000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	164000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2717000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2294000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2231000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2458000000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4760000000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4760000000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4760000000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4812000000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4812000000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4812000000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	245000000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	265000000	usd
CY2024Q1	ctsh	Capitalized Contract Cost Costs Capitalized CapitalizedContractCostCostsCapitalized	14000000	usd
CY2023Q1	ctsh	Capitalized Contract Cost Costs Capitalized CapitalizedContractCostCostsCapitalized	15000000	usd
CY2024Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	-24000000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	-22000000	usd
CY2024Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	235000000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	258000000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Gross ContractWithCustomerAssetGross	316000000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Gross ContractWithCustomerAssetGross	326000000	usd
CY2024Q1	ctsh	Contract With Customer Asset Revenue Recognized But Not Billed ContractWithCustomerAssetRevenueRecognizedButNotBilled	248000000	usd
CY2023Q1	ctsh	Contract With Customer Asset Revenue Recognized But Not Billed ContractWithCustomerAssetRevenueRecognizedButNotBilled	248000000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Reclassified To Receivable ContractWithCustomerAssetReclassifiedToReceivable	-180000000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Reclassified To Receivable ContractWithCustomerAssetReclassifiedToReceivable	-223000000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerAssetIncreaseDecreaseForContractAcquiredInBusinessCombination	0	usd
CY2023Q1	us-gaap	Contract With Customer Asset Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerAssetIncreaseDecreaseForContractAcquiredInBusinessCombination	9000000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Gross ContractWithCustomerAssetGross	384000000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Gross ContractWithCustomerAssetGross	360000000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	427000000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	417000000	usd
CY2024Q1	ctsh	Contract With Customer Liability Amount Billed But Revenue Not Recognized ContractWithCustomerLiabilityAmountBilledButRevenueNotRecognized	311000000	usd
CY2023Q1	ctsh	Contract With Customer Liability Amount Billed But Revenue Not Recognized ContractWithCustomerLiabilityAmountBilledButRevenueNotRecognized	322000000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-262000000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-251000000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	9000000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	13000000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	485000000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	501000000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4263000000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	32000000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	43000000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1000000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4000000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	3000000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	11000000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	30000000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	36000000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	146000000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	464000000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	500000000	usd
CY2024Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	2096000000	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	2425000000	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	12000000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	14000000	usd
CY2024Q1	us-gaap	Long Term Investments LongTermInvestments	83000000	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	435000000	usd
CY2023Q4	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	96000000	usd
CY2024Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	0	usd
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	3000000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	3000000	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	77000000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	74000000	usd
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	6000000	usd
CY2024Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	6000000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1158000000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1511000000	usd
CY2024Q1	ctsh	Customer Volumeand Other Incentives Current CustomerVolumeandOtherIncentivesCurrent	291000000	usd
CY2023Q4	ctsh	Customer Volumeand Other Incentives Current CustomerVolumeandOtherIncentivesCurrent	241000000	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	30000000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	27000000	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	153000000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	598000000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	606000000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.248
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.214
CY2023Q4	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	96000000	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	33000000	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	3000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	20000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	15000000	usd
CY2024Q1	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	15000000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	695000000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	702000000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1036000000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1048000000	usd
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001058290-24-000116-index-headers.html	Edgar Link	pending
0001058290-24-000116-index.html	Edgar Link	pending
0001058290-24-000116.txt	Edgar Link	pending
0001058290-24-000116-xbrl.zip	Edgar Link	pending
ctsh-20240331.htm	Edgar Link	pending
ctsh-20240331.xsd	Edgar Link	pending
ctsh-20240331_g1.jpg	Edgar Link	pending
ctsh-20240331_g10.jpg	Edgar Link	pending
ctsh-20240331_g11.jpg	Edgar Link	pending
ctsh-20240331_g12.jpg	Edgar Link	pending
ctsh-20240331_g13.jpg	Edgar Link	pending
ctsh-20240331_g14.jpg	Edgar Link	pending
ctsh-20240331_g15.jpg	Edgar Link	pending
ctsh-20240331_g16.jpg	Edgar Link	pending
ctsh-20240331_cal.xml	Edgar Link	unprocessable
ctsh-20240331_def.xml	Edgar Link	unprocessable
ctsh-20240331_g17.jpg	Edgar Link	pending
ctsh-20240331_g18.jpg	Edgar Link	pending
ctsh-20240331_g2.jpg	Edgar Link	pending
ctsh-20240331_g3.jpg	Edgar Link	pending
ctsh-20240331_g4.jpg	Edgar Link	pending
ctsh-20240331_g5.jpg	Edgar Link	pending
ctsh-20240331_g6.jpg	Edgar Link	pending
ctsh-20240331_g7.jpg	Edgar Link	pending
ctsh-20240331_g8.jpg	Edgar Link	pending
ctsh-20240331_g9.jpg	Edgar Link	pending
ctshexhibit3113312024.htm	Edgar Link	pending
ctshexhibit3123312024.htm	Edgar Link	pending
ctshexhibit3213312024.htm	Edgar Link	pending
ctshexhibit3223312024.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
ctsh-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ctsh-20240331_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ctsh-20240331_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CTSH
COGNIZANT TECHNOLOGY SOLUTIONS CORP Stock $ctsh

2024 Q2 Form 10-Q Financial Statement

#000105829024000116 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTSH COGNIZANT TECHNOLOGY SOLUTIONS CORP Stock $ctsh

2024 Q2 Form 10-Q Financial Statement

#000105829024000116 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTSH
COGNIZANT TECHNOLOGY SOLUTIONS CORP Stock $ctsh